The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Anticancer Mechanisms of Cannabinoids
Open accessAbstract
In addition to the well-known palliative effects of cannabinoids on some cancer-associated symptoms, a large body of evidence shows that these molecules can decrease tumour growth in animal models of cancer. They do so by modulating key cell signalling pathways involved in the control of cancer cell proliferation and survival. In addition, cannabinoids inhibit angiogenesis and decrease metastasis in various tumour types in laboratory animals. In this review, we discuss the current understanding of cannabinoids as antitumour agents, focusing on recent discoveries about their molecular mechanisms of action, including resistance mechanisms and opportunities for their use in combination therapy. Those observations have already contributed to the foundation for the development of the first clinical studies that will analyze the safety and potential clinical benefit of cannabinoids as anticancer agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Pertwee, R. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,935
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
Life and death partners: apoptosis, autophagy and the cross-talk between them
Eisenberg-Lerner, A., Bialik, S., Simon, H.-U., & Kimchi, A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.33 · Cited by 1,183
Autophagy in malignant transformation and cancer progression
Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490784 · Cited by 1,182
Self-citationMonoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002
TRB3: A tribbles Homolog That Inhibits Akt/PKB Activation by Insulin in Liver
Du, K., Herzig, S., Kulkarni, R. N., & Montminy, M. (2003) · Science · doi:10.1126/science.1079817 · Cited by 842
Cannabinoids: potential anticancer agents
Guzmán, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1188 · Cited by 703
Self-citationSalazar, M., Carracedo, A., Salanueva, Í. J., Hernández-Tiedra, S., Lorente, M., Egia, A., Vázquez, P., Blázquez, C., Torres, S., García, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37948 · Cited by 686
Self-citationGalve-Roperh, I., Sánchez, C., Cortés, M. L., del Pulgar, T. G., Izquierdo, M., & Guzmán, M. (2000) · Nature Medicine · doi:10.1038/73171 · Cited by 682
Self-citationCB2: a cannabinoid receptor with an identity crisis
Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 619
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
Katona, I., & Freund, T. F. (2008) · Nature Medicine · doi:10.1038/nm.f.1869 · Cited by 579
Ligresti, A., Moriello, A. S., Starowicz, K., Matias, I., Pisanti, S., De Petrocellis, L., Laezza, C., Portella, G., Bifulco, M., & Di Marzo, V. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105247 · Cited by 568
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
Steffens, S., Veillard, N. R., Arnaud, C., Pelli, G., Burger, F., Staub, C., Zimmer, A., Frossard, J.-L., & Mach, F. (2005) · Nature · doi:10.1038/nature03389 · Cited by 472
Shrivastava, A., Kuzontkoski, P. M., Groopman, J. E., & Prasad, A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1100 · Cited by 449
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
Casanova, M., Blázquez, C., Martínez‐Palacio, J., Villanueva, C., Fernández‐Aceñero, M. J., Huffman, J. W., Jorcano, J. L., & Guzmán, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16116 · Cited by 437
Self-citationEmerging strategies for exploiting cannabinoid receptor agonists as medicines
Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436
Anaplastic lymphoma kinase: signalling in development and disease
Palmer, R. H., Vernersson, E., Grabbe, C., & Hallberg, B. (2009) · Biochemical Journal · doi:10.1042/bj20090387 · Cited by 423
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
Sánchez, C., CEBALLOS, M. L. D., del Pulgar, T. G., Rueda, D., Corbacho, C., Velasco, G., Galve‐Roperh, I., Huffman, J. W., y Cajal, S. R., & Guzmán, M. (2001) · Cancer Research · Cited by 422
Self-citationTowards the use of cannabinoids as antitumour agents
Velasco, G., Sánchez, C., & Guzmán, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3247 · Cited by 372
Self-citationA pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
Guzmán, M., Duarte, M. J., Blázquez, C., Ravina, J., Rosa, M. C., Galve-Roperh, I., Sánchez, C., Velasco, G., & González-Feria, L. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603236 · Cited by 365
Self-citationCannabinoid CB2 receptor: a new target for controlling neural cell survival?
Fernández-Ruiz, J., Romero, J., Velasco, G., Tolón, R. M., Ramos, J. A., & Guzmán, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.11.001 · Cited by 362
Self-citationCarracedo, A., Gironella, M., Lorente, M., Garcia, S., Guzmán, M., Velasco, G., & Iovanna, J. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0169 · Cited by 354
Self-citationThe stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells
Carracedo, A., Lorente, M., Egia, A., Blázquez, C., García, S., Giroux, V., Malicet, C., Villuendas, R., Gironella, M., González-Feria, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.005 · Cited by 352
Self-citationLinking ER Stress to Autophagy: Potential Implications for Cancer Therapy
Verfaillie, T., Salazar, M., Velasco, G., & Agostinis, P. (2010) · International Journal of Cell Biology · doi:10.1155/2010/930509 · Cited by 346
Self-citationTranslating cancer research into targeted therapeutics
de Bono, J. S., & Ashworth, A. (2010) · Nature · doi:10.1038/nature09339 · Cited by 335
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Torres, S., Lorente, M., Rodríguez-Fornés, F., Hernández-Tiedra, S., Salazar, M., García-Taboada, E., Barcia, J., Guzmán, M., & Velasco, G. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0688 · Cited by 301
Self-citationCannabinoid receptors as novel targets for the treatment of melanoma
Blázquez, C., Carracedo, A., Barrado, L., José Real, P., Luis Fernández‐Luna, J., Velasco, G., Malumbres, M., Guzmán, M., Blázquez, C., Carracedo, A., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6638fje · Cited by 292
Self-citationInhibition of tumor angiogenesis by cannabinoids
Blázquez, C., Casanova, M. L., Planas, A., Gómez del Pulgar, T., Villanueva, C., Fernández‐Aceñero, M. J., Aragonés, J., Huffman, J. W., Jorcano, J. L., & Guzmán, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0795fje · Cited by 292
Self-citationHart, S., Fischer, O. M., & Ullrich, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3720 · Cited by 288
Possible endocannabinoid control of colorectal cancer growth
Ligresti, A., Bisogno, T., Matias, I., De Petrocellis, L., Cascio, M. G., Cosenza, V., D’argenio, G., Scaglione, G., Bifulco, M., Sorrentini, I., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00881-3 · Cited by 287
Cannabinoids for Cancer Treatment: Progress and Promise
Sarfaraz, S., Adhami, V. M., Syed, D. N., Afaq, F., & Mukhtar, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2785 · Cited by 275
Vara, D., Salazar, M., Olea-Herrero, N., Guzmán, M., Velasco, G., & Díaz-Laviada, I. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.32 · Cited by 268
Self-citationCannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
Blázquez, C., González-Feria, L., Álvarez, L., Haro, A., Casanova, M. L., & Guzmán, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3927 · Cited by 255
Zhu, L. X., Sharma, S., Stolina, M., Gardner, B., Roth, M. D., Tashkin, D. P., & Dubinett, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.373 · Cited by 252
Nabissi, M., Morelli, M. B., Santoni, M., & Santoni, G. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs328 · Cited by 248
McKallip, R. J., Nagarkatti, M., & Nagarkatti, P. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3281 · Cited by 245
McAllister, S. D., Murase, R., Christian, R. T., Lau, D., Zielinski, A. J., Allison, J., Almanza, C., Pakdel, A., Lee, J., Limbad, C., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1177-4 · Cited by 229
Donadelli, M., Dando, I., Zaniboni, T., Costanzo, C., Dalla Pozza, E., Scupoli, M. T., Scarpa, A., Zappavigna, S., Marra, M., Abbruzzese, A., et al. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.36 · Cited by 228
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
Qamri, Z., Preet, A., Nasser, M. W., Bass, C. E., Leone, G., Barsky, S. H., & Ganju, R. K. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0448 · Cited by 224
Ramer, R., & Hinz, B. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djm268 · Cited by 222
Caffarel, M. M., Sarrió, D., Palacios, J., Guzmán, M., & Sánchez, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4566 · Cited by 221
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
McAllister, S. D., Christian, R. T., Horowitz, M. P., Garcia, A., & Desprez, P.-Y. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0371 · Cited by 220
The endocannabinoid system and cancer: therapeutic implication
Guindon, J., & Hohmann, A. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01327.x · Cited by 200
Massi, P., Vaccani, A., Bianchessi, S., Costa, B., Macchi, P., & Parolaro, D. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6156-x · Cited by 196
De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis
del Pulgar, T. G., Velasco, G., Sánchez, C., Haro, A., & Guzmán, M. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3630183 · Cited by 186
Self-citationSarfaraz, S., Afaq, F., Adhami, V. M., Malik, A., & Mukhtar, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603495200 · Cited by 186
Portella, G., Laezza, C., Laccetti, P., De Petrocellis, L., Di Marzo, V., & Bifulco, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-1129fje · Cited by 184
Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression
Blázquez, C., Salazar, M., Carracedo, A., Lorente, M., Egia, A., González-Feria, L., Haro, A., Velasco, G., & Guzmán, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5176 · Cited by 184
Self-citationMarcu, J. P., Christian, R. T., Lau, D., Zielinski, A. J., Horowitz, M. P., Lee, J., Pakdel, A., Allison, J., Limbad, C., Moore, D. H., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0407 · Cited by 173
Preet, A., Ganju, R. K., & Groopman, J. E. (2008) · Oncogene · doi:10.1038/sj.onc.1210641 · Cited by 172
Anandamide inhibits adhesion and migration of breast cancer cells
Grimaldi, C., Pisanti, S., Laezza, C., Malfitano, A. M., Santoro, A., Vitale, M., Caruso, M. G., Notarnicola, M., Iacuzzo, I., Portella, G., et al. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.024 · Cited by 166
Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth
Wang, D., Wang, H., Ning, W., Backlund, M. G., Dey, S. K., & DuBois, R. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0896 · Cited by 166
Ellert-Miklaszewska, A., Kaminska, B., & Konarska, L. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.05.011 · Cited by 165
Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death
Armstrong, J. L., Hill, D. S., McKee, C. S., Hernandez-Tiedra, S., Lorente, M., Lopez-Valero, I., Eleni Anagnostou, M., Babatunde, F., Corazzari, M., Redfern, C. P. F., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.45 · Cited by 161
Self-citationSoroceanu, L., Murase, R., Limbad, C., Singer, E. A., Allison, J., Adrados, I., Kawamura, R., Pakdel, A., Fukuyo, Y., Nguyen, D., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1943 · Cited by 158
Scott, K. A., Dalgleish, A. G., & Liu, W. M. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0402 · Cited by 155
Massi, P., Valenti, M., Vaccani, A., Gasperi, V., Perletti, G., Marras, E., Fezza, F., Maccarrone, M., & Parolaro, D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05073.x · Cited by 144
Control by the endogenous cannabinoid system of ras oncogene‐dependent tumor growth
Bifulco, M., Laezza, C., Portella, G., Vitale, M., Orlando, P., PETROCELLIS, L. D., & Marzo, V. D. (2001) · The FASEB Journal · doi:10.1096/fj.01-0320fje · Cited by 140
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation
BURSTEIN, S. H., & Zurier, R. B. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9084-5 · Cited by 139
Mechanisms of Control of Neuron Survival by the Endocannabinoid System
Galve‐Roperh, I., Aguado, T., Palazuelos, J., & Guzmán, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740117 · Cited by 137
Self-citationCannabinoids: A new hope for breast cancer therapy?
Caffarel, M. M., Andradas, C., Pérez-Gómez, E., Guzmán, M., & Sánchez, C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.06.005 · Cited by 134
Self-citationHuman p8 Is a HMG-I/Y-like Protein with DNA Binding Activity Enhanced by Phosphorylation
Encinar, J. A., Mallo, G. V., Mizyrycki, C., Giono, L. E., González-Ros, J. M., Rico, M., Cánepa, E. T., Moreno, S., Neira, J. L., & Iovanna, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008594200 · Cited by 129
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
Pérez-Gómez, E., Andradas, C., Blasco-Benito, S., Caffarel, M. M., García-Taboada, E., Villa‐Morales, M., Moreno, E., Hamann, S., Martín-Villar, E., Flores, J. M., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv077 · Cited by 127
Self-citationToxicity and Carcinogenicity of Δ9-Tetrahydrocannabinol in Fischer Rats and B6C3F1 Mice
Chan, P. C., Sills, R. C., Braun, A. G., Haseman, J. K., & Bucher, J. R. (1996) · Fundamental and Applied Toxicology · doi:10.1006/faat.1996.0048 · Cited by 123
Advances in the genetics of glioblastoma: are we reaching critical mass?
Purow, B. W., & Schiff, D. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.96 · Cited by 118
Hegde, V. L., Nagarkatti, M., & Nagarkatti, P. S. (2010) · European Journal of Immunology · doi:10.1002/eji.201040667 · Cited by 117
Targeting Oncogenic ALK: A Promising Strategy for Cancer Treatment
Grande, E., Bolós, M. V., & Arriola, E. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0615 · Cited by 111
Therapeutic options for recurrent high-grade glioma in adult patients: Recent advances
Nieder, C., Adam, M., Molls, M., & Grosu, A. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.06.007 · Cited by 110
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon
Izzo, A. A., Aviello, G., Petrosino, S., Orlando, P., Marsicano, G., Lutz, B., Borrelli, F., Capasso, R., Nigam, S., Capasso, F., et al. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0248-4 · Cited by 109
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action
Lorente, M., Torres, S., Salazar‐Roa, M., Carracedo, A., Hernández‐Tiedra, S., Rodríguez-Fornés, F., García-Taboada, E., Meléndez, B., Mollejo, M., Campos‐Martín, Y., et al. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2010.170 · Cited by 108
Self-citationPisanti, S., Borselli, C., Oliviero, O., Laezza, C., Gazzerro, P., & Bifulco, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20954 · Cited by 108
Zheng, D., Bode, A. M., Zhao, Q. J., Cho, Y., Zhu, F., Ma, W.-Y., & Dong, Z. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6594 · Cited by 98
Cudaback, E., Marrs, W., Moeller, T., & Stella, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008702 · Cited by 96
Caffarel, M. M., Moreno‐Bueno, G., Cerutti, C., Palacios, J., Guzmán, M., Mechta‐Grigoriou, F., & Sánchez, C. (2008) · Oncogene · doi:10.1038/onc.2008.145 · Cited by 88
Self-citationGustafsson, S. B., Lindgren, T., Jönsson, M. E., & Jacobsson, S. O. P. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0788-5 · Cited by 85
Update on the endocannabinoid system as an anticancer target
Malfitano, A. M., Ciaglia, E., Gangemi, G., Gazzerro, P., Laezza, C., & Bifulco, M. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.553606 · Cited by 79
Thors, L., Bergh, A. R. J., Persson, E., Hammarsten, P., Stattin, P. E., Egevad, L., Granfors, T., & Fowler, C. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012275 · Cited by 75
Identification of midkine as a mediator for intercellular transfer of drug resistance
Mirkin, B. L., Clark, S. H., Zheng, X. S., Chu, F., White, B. D., Greene, M. E., & Rebbaa, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208671 · Cited by 75
Adjuvant chemotherapy in the treatment of high grade gliomas
Lonardi, S., Tosoni, A., & Brandes, A. A. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.12.005 · Cited by 75
Pharmacological Synergism Between Cannabinoids and Paclitaxel in Gastric Cancer Cell Lines
Miyato, H., Kitayama, J., Yamashita, H., Souma, D., Asakage, M., Yamada, J., & Nagawa, H. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.06.045 · Cited by 74
Lu, T., Newton, C. A., Perkins, I., Friedman, H. P., & Klein, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.108381 · Cited by 70
Newton, C. A., Chou, P.-J., Perkins, I., & Klein, T. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9126-2 · Cited by 62
The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action
Salazar‐Roa, M., Lorente, M., García-Taboada, E., Hernández‐Tiedra, S., Dávila, D., Francis, S., Guzmán, M., Kiss‐Toth, E., & Velasco, G. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.03.014 · Cited by 56
Self-citationAmphiregulin is a factor for resistance of glioma cells to cannabinoid‐induced apoptosis
Lorente, M., Carracedo, A., Torres, S., Natali, F., Egia, A., Hernández‐Tiedra, S., Salazar‐Roa, M., Blázquez, C., Guzmán, M., & Velasco, G. (2009) · Glia · doi:10.1002/glia.20856 · Cited by 41
Self-citationLeukemic predisposition of pSca-1/Cb2 transgenic mice
Joosten, M., Valk, P. J. M., Alberich-Jordà, M., Vankan, Y., Verbakel, S. E., Broek, M. V. D., Beijen, A., Löwenberg, B., & Delwel, R. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00779-2 · Cited by 30
Cited by
Almansour, N. M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.836417 · Cited by 397
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 358
Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
Medina, M. A., Oza, G., Sharma, A., Arriaga, L. G., Hernández Hernández, J. M., Rotello, V. M., & Ramirez, J. T. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17062078 · Cited by 333
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303
Metadata
- Authors
- Velasco, G., Sánchez, C., & Guzmán, M.
- Venue
- Current Oncology
- Publisher
- MDPI AG
- Published
- 2016-03-01
- Volume
- 23
- Issue
- 11
- Pages
- 23-32
- ISSN
- 1198-0052 (ISSN-L)
- 1718-7729
- OpenAlex
- W2305988154
- Cited by
- 265
- References
- 95
- FWCI
- 16.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.